Search research articles
Contact Us
Filters
Showing results (511-520 of 678) with videos related to
Page
of 68
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 26, 2016
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
Désirée van der Heijde, Robert B Landewé, Philip J Mease, et al.
The Journal of Nutrition
|
December 25, 2008
Plasma adiponectin concentrations are associated with body composition and plant-based dietary factors in female twins
Aedin Cassidy, Paula Skidmore, Eric B Rimm, et al.
ACR Open Rheumatology
|
January 21, 2020
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study
Karel Pavelka, Alan J Kivitz, Eva Dokoupilova, et al.
Annals of Internal Medicine
|
December 1, 1994
Lack of HIV transmission in the practice of a dentist with AIDS
H W Jaffe, J M McCurdy, M L Kalish, et al.
Journal of Intensive Care Medicine
|
June 26, 2023
Timing of Transport of Patients with COVID-19
Jane M Hayes, Jeremy B Richards, Michael A Frakes, et al.
Environmental Research
|
September 24, 2022
Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics
A Gómez-Carballa, J Pardo-Seco, S Pischedda, et al.
Arthritis Research & Therapy
|
July 19, 2006
Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases
Yoshioki Yamasaki, Sonali Narain, Liza Hernandez, et al.
The Journal of Urology
|
October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma
F M Debruyne, L Denis, G Lunglmayer, et al.
The British Journal of Dermatology
|
October 31, 2012
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
K A Papp, R G Langley, B Sigurgeirsson, et al.
Cells
|
November 26, 2025
Calmodulin D133H Disrupts Ca<sub>v</sub>1.2 and K<sub>v</sub>7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome
Nitika Gupta, Liam F McCormick, Ella M B Richards, et al.
Page
of 68
Search research articles
Search
Showing results (511-520 of 678) with videos related to
Sort By:
Page
of 68
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 26, 2016
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
Désirée van der Heijde, Robert B Landewé, Philip J Mease, et al.
The Journal of Nutrition
|
December 25, 2008
Plasma adiponectin concentrations are associated with body composition and plant-based dietary factors in female twins
Aedin Cassidy, Paula Skidmore, Eric B Rimm, et al.
ACR Open Rheumatology
|
January 21, 2020
Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3-Year Results from the Phase 3 MEASURE 3 Study
Karel Pavelka, Alan J Kivitz, Eva Dokoupilova, et al.
Annals of Internal Medicine
|
December 1, 1994
Lack of HIV transmission in the practice of a dentist with AIDS
H W Jaffe, J M McCurdy, M L Kalish, et al.
Journal of Intensive Care Medicine
|
June 26, 2023
Timing of Transport of Patients with COVID-19
Jane M Hayes, Jeremy B Richards, Michael A Frakes, et al.
Environmental Research
|
September 24, 2022
Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics
A Gómez-Carballa, J Pardo-Seco, S Pischedda, et al.
Arthritis Research & Therapy
|
July 19, 2006
Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases
Yoshioki Yamasaki, Sonali Narain, Liza Hernandez, et al.
The Journal of Urology
|
October 1, 1988
Long-term therapy with a depot luteinizing hormone-releasing hormone analogue (Zoladex) in patients with advanced prostatic carcinoma
F M Debruyne, L Denis, G Lunglmayer, et al.
The British Journal of Dermatology
|
October 31, 2012
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
K A Papp, R G Langley, B Sigurgeirsson, et al.
Cells
|
November 26, 2025
Calmodulin D133H Disrupts Ca<sub>v</sub>1.2 and K<sub>v</sub>7.1 Regulation to Prolong Cardiac Action Potentials in Long QT Syndrome
Nitika Gupta, Liam F McCormick, Ella M B Richards, et al.
Page
of 68